CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velázquez, B.
Right arrow Articles by Chabalgoity, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velázquez, B.
Right arrow Articles by Chabalgoity, J. A.

 Previous Article

Clinical and Diagnostic Laboratory Immunology, May 2005, p. 683-684, Vol. 12, No. 5
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.5.683-684.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Construction and Expression of Recombinant Streptolysin-O and Preevaluation of Its Use in Immunoassays

Blanca Velázquez,1 Hugo Massaldi,1 Julio Battistoni,2 and José A. Chabalgoity1*

Department of Biotechnology, Institute of Hygiene, School of Medicine, Universidad de la República, Uruguay, Av. Alfredo Navarro 3051, Montevideo, Uruguay,1 Laboratory of Immunotechnology, Department of Immunology, School of Chemistry-School of Science, Universidad de la República, Av. Alfredo Navarro 3051, Montevideo, Uruguay2

Received 22 November 2004/ Returned for modification 3 January 2005/ Accepted 14 March 2005

Commercially available immunoassays for assessment of anti-streptolysin-O antibodies use native streptolysin-O obtained by a complex process. We prepared a biologically active recombinant streptolysin-O with higher yield and a simpler purification process. An enzyme-linked immunosorbent assay developed with this recombinant showed good correlation with a commercial test, suggesting that it could be suitable for immunoassays.


* Corresponding author. Mailing address: Laboratory for Vaccine Research, Department of Biotechnology, Institute of Hygiene, School of Medicine, Universidad de la República, Av. Alfredo Navarro 3051, Montevideo, R.O. Uruguay. Phone: (00598) 2 4871288, ext. 1120. Fax: (00598) 2 4871288, ext. 1102. E-mail: jachabal{at}higiene.edu.uy.


Clinical and Diagnostic Laboratory Immunology, May 2005, p. 683-684, Vol. 12, No. 5
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.5.683-684.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.